SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description

Login to view
Course Activities.

CME Live Virtual Conferences

Go Back

Mark Stolar, MD
Associate Professor of Clinical Medicine
Feinberg School of Medicine
Northwestern University
Chicago, IL

Gregg Sherman, MD
Family Practice
Plantation, FL

: The Progression of Type 2 Diabetes: A Rational Approach for Long-term Disease Management
Activity/Course #:
: NCME355x

: Free
Release/Start Date:
: Aug 01 2018
Expiration Date:
: Jul 31 2019
: Diabetes
Target Audience:
: Primary Care Physicians, Nurse Practitioners and Physician Assistants
: Webcast
Estimated Time To Complete CME Activity:
: 1.0 Hour
: 0
Hardware/Software Requirements:
Program Summary

Type 2 diabetes (T2DM) accounts for about 90-95% of diabetes cases in adults, and its increasing onset at an earlier age makes updated disease management strategies essential. Since T2DM is a progressive, multi-defect disorder treatment strategies should be aimed at correcting the multiple pathophysiological defects involved. Clinicians face challenges in choosing the most appropriate antidiabetic agent for each patient, and clinical guidelines may not address issues in specific patients. New and emerging data demonstrates the effectiveness of combination therapy for some patients with type 2 diabetes management, however, individualizing treatment strategies often become challenging. Moreover, good provider-patient communication can facilitate lifestyle modification and medication adherence, but in practice, provider-patient communication may be inadequate, which in turn affects collaborative diabetes management and adherence.

This activity will examine T2DM pathophysiology, the strength and limitations of current guidelines for diabetes management, provider-patient communication for increased adherence, and the current data on combination strategies that most effectively address pathophysiologic needs.

This webcast was recorded live at the Emerging Challenges in Primary Care Live Virtual Symposium 2018 and is being used with the permission of the presenters

Learning Objectives
After completing this program participants should be able to:
  1. Recognize the pathogenesis of type 2 diabetes (T2D) as a progressive, multi-defect disorder
  2. Discuss the strengths and limitations of current guidelines for diabetes management
  3. Successfully use strategies for adherence to multiple medications to improve outcomes in diabetes
  4. Examine data on current combination strategies to choose therapies that most effectively address a patient’s underlying pathophysiologic needs

How to obtain the CME Certificate

  1. Register for the course at
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 70% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hour of continuing education which includes 0.75 Pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosures are provided below.

Mark Stolar, MD, serves on the speakers bureau for Astra Zeneca.

Contributing Faculty
Rodolfo J. Galindo, MD, faculty, has no relevant financial relationships to disclose

Javier Morales, MD, FACP, FACE, faculty, serves on the speakers bureau and as a consultant for Lilly, Novo Nordisk, Janssen, and Abbott.

Leann Olansky, MD, FACP, FACE, faculty, has no relevant financial relationships to disclose.

Jeff Unger, MD, FAAFP, FACE, faculty, serves as a consultant, researcher

Activity Planning Committee
Gregg Sherman, MD, has no relationships to disclose.

Josh Killbridge, Medical Writer, has no relationship to disclose.

Harvey C. Parker, Ph.D., has no relationships to disclose.

Michelle Frisch, MPH, has no relationships to disclose.

Sheila Lucas, CWEP, has no relationships to disclose.

Sandy Bihlmeyer, MEd, has no relationship to disclose.

Alan Goodstat, LCSW, has no relationships to disclose.
Commercial Support
This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit